尿碘浓度与代谢性疾病患病率的U型关联:一项横断面研究
研究基于TIDE项目51,795名≥18岁受试者,按尿碘浓度(UIC)分层计算代谢性疾病患病率,并用二次及分层logistic回归分析关联。代谢性疾病患病率随UIC呈U型,UIC 300-499 μg/L时患病率较低为76.0%;UIC 300-499 μg/L与代谢性疾病(OR=0.857,95%CI 0.796-0.922)及高血压(OR=0.873,95%CI 0.814-0.936)相关。结论认为UIC与代谢性疾病及其相关疾病的关联呈U型,碘缺乏(<100 μg/L)或过量(≥500 μg/L)时该关联消失。
要点
- UIC 300-499 μg/L与代谢性疾病(OR=0.857)及高血压(OR=0.873)相关。
- UIC 500-799 μg/L与糖尿病前期相关(OR=0.883,95%CI 0.797-0.978)。
- UIC<100 μg/L与高血压(OR=1.097)和高胆固醇血症(OR=1.178)相关。
核心结论
- 成年人UIC与代谢性疾病及其相关疾病的关联呈U型,碘缺乏(<100 μg/L)或过量(≥500 μg/L)时UIC与代谢性疾病的关联消失。
研究设计与样本
- TIDE(甲状腺疾病、碘状态与糖尿病)全国流行病学横断面研究,纳入51,795名年龄≥18岁的受试者。
主要发现
- 代谢性疾病患病率随UIC呈U型,UIC 300-499 μg/L时患病率较低为76.0%。
- UIC 300-499 μg/L与代谢性疾病相关(OR=0.857,95%CI 0.796-0.922),也与高血压相关(OR=0.873,95%CI 0.814-0.936)。
- UIC 300-799 μg/L与代谢综合征及糖耐量受损的发生相关,UIC 500-799 μg/L与糖尿病前期相关(OR=0.883,95%CI 0.797-0.978)。
- UIC≥300 μg/L与高甘油三酯血症、高胆固醇血症及低密度脂蛋白胆固醇高水平的发生相关。
- UIC<100 μg/L与高血压相关(OR=1.097,95%CI 1.035-1.162),也与高胆固醇血症相关(OR=1.178,95%CI 1.117-1.242)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Iodine is important in both thyroid function and human metabolism. Studies have explored the effect of iodine on metabolic disorders through thyroid function. This study aimed to investigate the relationship between iodine status and metabolic disorders, such as metabolic syndrome (MetS), hypertension, impaired glucose metabolism, central obesity, and dyslipidemia. Methods: A total of 51,795 subjects aged ≥18 years from the TIDE (Thyroid Disorders, Iodine Status and Diabetes, a national epidemiological cross-sectional study) program were included. The prevalence of metabolic disorders and its related diseases was calculated based on the level of urinary iodine concentrations (UICs) using the chi-square method. To further explore whether the prevalence was associated with UIC, quadratic and UIC-stratified logistic regression models were used. Results: The prevalence of metabolic disorders as a function of UIC was found to be U-shaped with a lower prevalence of 76.0% at an UIC of 300-499 μg/L. Participants with an UIC of 300-499 μg/L showed an association with metabolic disorders (odds ratio [OR] = 0.857, 95% confidence interval [CI 0.796-0.922]) and hypertension (OR = 0.873 [CI 0.814-0.936]). An UIC of 300-799 μg/L was found to be associated with the occurrence of MetS and impaired glucose tolerance. An UIC of 500-799 μg/L was associated with the occurrence of prediabetes (OR = 0.883 [CI 0.797-0.978]). An UIC of ≥300 μg/L was associated with the occurrence of hypertriglyceridemia, hypercholesterolemia, and high levels of low-density lipoprotein cholesterol. Furthermore, an UIC of <100 μg/L showed an association with hypertension (OR = 1.097 [CI 1.035-1.162]) and hypercholesterolemia (OR = 1.178 [CI 1.117-1.242]). Conclusions: The association between UICs in adults and metabolic disorders and its related diseases is U-shaped. The association between UIC and metabolic disorders disappears in cases of iodine deficiency (<100 μg/L) or excess (≥500 μg/L).
引用
- Jin M, Zhang Z, Li Y, et al. U-Shaped Associations Between Urinary Iodine Concentration and the Prevalence of Metabolic Disorders: A Cross-Sectional Study. Thyroid. 2020. PMID: 32188373. doi:10.1089/thy.2019.0516
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。